Hard to use
The last app was much easier to use! It showed the algorithm with each mgmt decision. This one has too many outside links and vague recommendations.
ASCCP Management Guidelines
Published by:
American Society for Colposcopy and Cervical Pathology
Description
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.
ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines.
These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to:
• Allow for a more complete and precise estimation of risk
• Provide more appropriate intervention for high-risk individuals (detect and treat more precancer)
• Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm)
• Allow for the future addition of new risk modifiers and screening and management technologies
See https://www.asccp.org/UserGuide for tips on using the app.
Hide
Show More...
ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines.
These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to:
• Allow for a more complete and precise estimation of risk
• Provide more appropriate intervention for high-risk individuals (detect and treat more precancer)
• Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm)
• Allow for the future addition of new risk modifiers and screening and management technologies
See https://www.asccp.org/UserGuide for tips on using the app.
Screenshots
Loading...
Please wait..
ASCCP Management Guidelines FAQ
-
Is ASCCP Management Guidelines free?
ASCCP Management Guidelines is not free (it costs 799.99), however it doesn't contain in-app purchases or subscriptions.
-
Is ASCCP Management Guidelines legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does ASCCP Management Guidelines cost?
The price of ASCCP Management Guidelines is 799.99.
-
What is ASCCP Management Guidelines revenue?
To get estimated revenue of ASCCP Management Guidelines app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Egypt yet.
Ratings History
ASCCP Management Guidelines Reviews
Wow
Love this diagnostic tool. Easy to use, accurate.
So useful!!
I use this app nearly every day I’m the clinic to help evaluate results and guide clinical decisions. I love that it has the most up to date information. Would recommend for all clinicians who are evaluating paps and colposcopies.
“Manage per guidelines”
A lot of the algorithms mention “manage per 2019 guilds lines. But they don’t include what those guidelines are. Otherwise easy to use
Store Rankings
Ranking History
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Paid
|
|
1
|
|
Top Paid
|
|
3
|
|
Top Paid
|
|
4
|
|
Top Grossing
|
|
4
|
|
Top Grossing
|
|
4
|
ASCCP Management Guidelines Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
Contraception Point-of-Care
Joshua Steinberg & RHAP
|
Unlock
|
Unlock
|
0
|
|
2 weeks ago | |
USPSTF Prevention TaskForce
USPSTF Recommendations (ePSS)
|
Unlock
|
Unlock
|
0
|
|
2 months ago | |
CDC Vaccine Schedules
|
Unlock
|
Unlock
|
0
|
|
3 days ago | |
PneumoRecs VaxAdvisor
|
Unlock
|
Unlock
|
0
|
|
1 week ago | |
ASCVD Risk Estimator Plus
|
Unlock
|
Unlock
|
0
|
|
7 months ago | |
Contraception
|
Unlock
|
Unlock
|
0
|
|
4 months ago | |
STI Tx Guide
|
Unlock
|
Unlock
|
0
|
|
11 months ago | |
AAFP
Journals, CME & News
|
Unlock
|
Unlock
|
0
|
|
1 month ago | |
ACOG
|
Unlock
|
Unlock
|
1
|
|
1 year ago | |
ABFM CKSA
|
Unlock
|
Unlock
|
0
|
|
1 year ago |
ASCCP Management Guidelines Installs
Last 30 days
ASCCP Management Guidelines Revenue
Last 30 daysASCCP Management Guidelines Revenue and Downloads
Gain valuable insights into ASCCP Management Guidelines performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Languages
- English
- Recent release
- 2.0.1 (2 months ago )
- Released on
- Jun 5, 2020 (4 years ago )
- Also available in
- United States , Thailand , Türkiye , Poland , Colombia , Brazil , Mexico , Russia , Canada , Greece , Taiwan , China , Romania , Chile , Peru , Ecuador , Philippines , Malaysia , Belgium , South Korea , Vietnam , United Arab Emirates , Israel , Italy , United Kingdom , Portugal , Ukraine , Spain , Hungary , Indonesia , Kazakhstan , South Africa , Argentina , France , India , Dominican Republic , Hong Kong SAR China , Japan , Australia , Switzerland , Saudi Arabia , Germany , Kuwait , Austria , Azerbaijan , Belarus , Czechia , Singapore , Sweden , Denmark , Sri Lanka , Algeria , Pakistan , Egypt , Finland , New Zealand , Nepal , Norway , Netherlands , Nigeria , Ireland , Lebanon
- Last Updated
- 6 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.